We performed a systematic literature review and meta-analysis to evaluate the efficay of angiotensin-converting enzyme inhibitors in patients with coronary artery disease and normal systolic left ventricular function. Angiotensin-converting enzyme inhibitor use was associated with modest benefits, which included a reduction in cardiovascular mortality, nonfatal larizatton rates.
|Original language||English (US)|
|Number of pages||6|
|State||Published - Dec 1 2006|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine